Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sangamo Therapeutics (SGMO) Exchange Rate Effect (2018 - 2025)

Sangamo Therapeutics (SGMO) has 8 years of Exchange Rate Effect data on record, last reported at $42000.0 in Q3 2025.

  • For Q3 2025, Exchange Rate Effect fell 96.27% year-over-year to $42000.0; the TTM value through Sep 2025 reached $1.8 million, up 16.24%, while the annual FY2024 figure was -$2.0 million, 238.1% down from the prior year.
  • Exchange Rate Effect reached $42000.0 in Q3 2025 per SGMO's latest filing, down from $2.7 million in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $2.7 million in Q2 2025 and bottomed at -$2.2 million in Q4 2024.
  • Average Exchange Rate Effect over 5 years is $235631.6, with a median of $130000.0 recorded in 2022.
  • Peak YoY movement for Exchange Rate Effect: plummeted 533.07% in 2023, then soared 1163.04% in 2025.
  • A 5-year view of Exchange Rate Effect shows it stood at -$115000.0 in 2021, then surged by 773.91% to $775000.0 in 2022, then skyrocketed by 74.58% to $1.4 million in 2023, then tumbled by 266.08% to -$2.2 million in 2024, then surged by 101.87% to $42000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Exchange Rate Effect were $42000.0 in Q3 2025, $2.7 million in Q2 2025, and $1.3 million in Q1 2025.